Company Profiles

driven by the PitchBook Platform

Curacyte

Description

Developer of therapeutics for acute and critical care. The company develops new medicines in the areas of hematology, antithrombosis and oncology.

PRIVATE

Status

Grant

Latest Deal Type

$37.3M

Total Amount Raised

10

Investors

Description

Developer of therapeutics for acute and critical care. The company develops new medicines in the areas of hematology, antithrombosis and oncology.

Website:

www.curacyte.eu

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Drug Discovery

Primary Office

C/o Dornbach GmbH Arnulfstraße 39 80636 MunichGermany +49 (0)89 4120 0681
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Curacyte's full profile, request a free trial.

    Curacyte Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Curacyte Investors (10)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    AlpInvest PartnersPE/BuyoutMinority000 0000000 0000
    CFH BeteiligungsgesellschaftPE/BuyoutMinority000 0000000 0000
    dievini Hopp BioTechVenture CapitalMinority000 0000000 0000
    European UnionGovernment000 0000000 0000
    IBG Beteiligungsgesellschaft Sachsen-AnhaltVenture CapitalMinority000 0000000 0000
    AlpInvest Partners PE/Buyout
    CFH Beteiligungsgesellschaft PE/Buyout
    dievini Hopp BioTech Venture Capital
    European Union Government
    IBG Beteiligungsgesellschaft Sachsen-Anhalt Venture Capital

    Curacyte Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Christof Hettich JDManaging Director
    Christof Hettich JD Managing Director
    Request full access to PitchBook